leon-nanodrugs GmbH (“LEON”), the main enabler of nano expertise for the pharmaceutical trade, introduced at this time the appointment of Dr. Hans Frickel as CEO, efficient July 1, 2023.
Dr. Hans Frickel, a skilled pharmacist and industrial supervisor, brings greater than 20 years of expertise in strategic and operational management roles throughout all the worth chain of prescribed drugs and medical gadgets. Previous to becoming a member of LEON, he served as Managing Director at R‑Biopharm and held a number of senior operational administration roles at BioNTech, Evonik, Midas Pharma, Procter & Gamble and Merck.
Dr. Hubert Birner, Chairman of the LEON Supervisory Board, stated: “On behalf of the Supervisory Board, I’m delighted to welcome Dr. Hans Frickel to LEON. Along with his in depth experience in numerous areas of recent drug manufacturing, together with plant administration and QC, in addition to a robust observe document in technique and governance, he is a perfect match to take LEON to the subsequent stage. On behalf of the Supervisory Board I additionally want to thank our interim CEO and CFO Christian Nafe, our CSO Dr. Setu Kasera and their staff for his or her super work in driving our expertise in direction of commercialization and for the good progress that has been achieved up to now.”
“I’m excited to affix LEON as we work to rework nanomedicine manufacturing,” stated Dr. Hans Frickel, CEO of LEON. “I’m impressed with the staff’s information and dedication in working to create added worth throughout the nano formulation processing chain. I really consider that LEON’s NANO gadgets will considerably enhance improvement and manufacturing for present and future standardized and personalised cell & gene therapies at CDMOs, biotech and pharma corporations.”
Supply: https://leon-nanodrugs.com/
